Answers are grounded in this paper and cite their sources.
Background: Chondroblastomas are rare bone tumors, which are the cartilaginous origin and account for nearly 1% of all primary bone tumors. It can affect people of all ages. Chondroblastomas arising in the talus are very rare and are known to have less aggressive behavior. Methods: 11 authors, a total of 572 patient data with our talus case, were analyzed for this review literature. Here is the mentioning of epidemiological and clinical information, radiological details, surgery type, adjuvants types, genders, follow-up years, recurrence, affected areas, death rates, successful outcome, MSTS functionality scores, and survival rates by analyzing all data. Result: Chondroblastoma was treated by curettage and bone grafting during surgical procedures. This procedure is curative in 90% of cases. There was no recurrence in this study case of the talus. Also, the MSTS functionality score for CB averages 90% more in most of the author’s literature, and 0% death rate was reported. Conclusion: We believe that chondroblastoma of the talus bone should be considered among the differential diagnosis whenever a neoplastic cause is being considered as the underlying pathologic entity. We present a review of the literature detailing their occurrence, radiological findings, and treatments and to report functional outcomes after treatments, which have been rarely documented in a large series.
No takes yet. Share an insight, caveat, or question.
Jami et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: